The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Limited Competition: Data Coordinating Center for the Accelerating Medicines Partnership Target Discovery and Preclinical Validation Consortium AMP-AD DCC (U24- Clinical Trial Not Allowed )
The goal of this funding opportunity announcement is to solicit applications focused on 1) providing data enablement for the open-science, systems-biology enterprise of the AMP-AD Target Discovery and Preclinical Validation Consortiumsupported through the companion FOA (RFA-AG-18-013) and 2) sustaining and expanding the big-data infrastructure of the AMP-AD Knowledge Portal as a collaborative research platform through which members of the Consortium, researchers at large, and citizen scientists can engage in rapid translational learning and contribute to the development of predictive models of AD and AD-related dementias.
- Letter of Intent: January 20, 2018
- Application Due Date(s): February 20, 2018
RFA-AG-18-014 Expiration Date February 21, 2018
Only institutions that have previously received a sub-award for data enablement of the AMP-AD Target Discovery and Preclinical Validation Project and for development of the AMP-AD Knowledge Portal (RFA-AG-13-013) are eligible to submit an application in response to this FOA.
Annual direct costs are capped at $750,000.
The maximum project period is 5 years.